Profil
Nicholas Williams is currently a Board Director at Alderaan Biotechnology SAS, a Non-Executive Director at Versanis Bio, Inc., and a Partner at Medicxi Ventures (Jersey) Ltd. He graduated from the University of Cardiff.
Aktive Positionen von Nicholas Williams
| Unternehmen | Position | Beginn |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Private-Equity-Analyst | - |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer | Direktor/Vorstandsmitglied | - |
Ausbildung von Nicholas Williams
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Finance |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer | Health Technology |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
















